Fig. 6

Down-expression of TNFRSF1B reverses the effect of miR-125a-5p in RAW 264.7 cells. a RAW 264.7 cells that were treated with anti-miR-125a-5p and siTNFRSF1B were subjected to immunoblotting assay. b RAW 264.7 cells were treated with anti-miR-125a-5p alone or anti-miR-125a-5p in combination with siTNFRSF1B. The proliferation of RAW 264.7 cells was detected using MTT assay. c The migration of RAW 264.7 cells was determined by wound healing assay. d RAW 264.7 cells were treated with anti-miR-125a-5p alone or anti-miR-125a-5p in combination with siTNFRSF1B. The invasion of RAW 264.7 cells was analyzed by Transwell invasion assay. ^** P < 0.01 compared to control, ^## P < 0.01 compared to anti-miR-125a-5p